AVITA Medical, Inc. (RCEL)
15.63
-0.57
(-3.52%)
USD |
NASDAQ |
Nov 13, 16:00
15.60
-0.03
(-0.19%)
After-Hours: 19:59
AVITA Medical Market Cap : 483.94M for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 483.94M |
| November 12, 2026 | 501.59M |
| November 11, 2026 | 535.65M |
| November 10, 2026 | 546.49M |
| November 09, 2026 | 530.08M |
| November 06, 2026 | 513.67M |
| November 05, 2026 | 485.49M |
| November 04, 2026 | 505.31M |
| November 03, 2026 | 474.66M |
| November 02, 2026 | 476.58M |
| October 30, 2026 | 484.00M |
| October 29, 2026 | 516.79M |
| October 28, 2026 | 510.29M |
| October 27, 2026 | 497.30M |
| October 26, 2026 | 469.47M |
| October 23, 2026 | 479.67M |
| October 22, 2026 | 476.89M |
| October 21, 2026 | 472.87M |
| October 20, 2026 | 426.79M |
| October 19, 2026 | 406.38M |
| October 16, 2026 | 403.29M |
| October 15, 2026 | 414.73M |
| October 14, 2026 | 405.14M |
| October 13, 2026 | 413.18M |
| October 12, 2026 | 413.49M |
| Date | Value |
|---|---|
| October 09, 2026 | 408.54M |
| October 08, 2026 | 412.25M |
| October 07, 2026 | 403.59M |
| October 06, 2026 | 401.74M |
| October 05, 2026 | 409.78M |
| October 02, 2026 | 393.39M |
| October 01, 2026 | 371.43M |
| September 30, 2026 | 362.77M |
| September 29, 2026 | 369.88M |
| September 28, 2026 | 360.92M |
| September 25, 2026 | 366.17M |
| September 24, 2026 | 358.13M |
| September 23, 2026 | 338.65M |
| September 22, 2026 | 355.35M |
| September 21, 2026 | 335.25M |
| September 18, 2026 | 340.81M |
| September 17, 2026 | 347.00M |
| September 16, 2026 | 323.19M |
| September 15, 2026 | 315.76M |
| September 14, 2026 | 315.14M |
| September 11, 2026 | 305.56M |
| September 10, 2026 | 304.94M |
| September 09, 2026 | 314.22M |
| September 08, 2026 | 321.95M |
| September 04, 2026 | 346.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Iovance Biotherapeutics, Inc. | 3.589B |
| Halozyme Therapeutics, Inc. | 11.42B |
| Agenus, Inc. | 304.25M |
| Amgen, Inc. | 251.88B |
| Fate Therapeutics, Inc. | 155.56M |
Market Cap Related Metrics
| PS Ratio | 5.654 |
| Price | 15.63 |
| Earnings Yield | -7.55% |